of borderline significanceP = .007
The greater proportion of patients with prostate cancer treated with aMRI LINAC were treated at an academic center versus patients with prostate cancer treated with IMRT was of borderline significance ( P = .007).
The greater proportion of patients with prostate cancer treated with aMRI LINAC were treated at an academic center versus patients with prostate cancer treated with IMRT was of borderline significance ( P = .007).